Finance

Lists
VERA:NASDAQ
Vera Therapeutics, Inc
US$ २९.८३
-१.९४%
(-०.५९) 1D
US$ ३०.००
+०.५७% (+०.१७)
After hours
Closed: अक्टोबर ५, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VERA...
Open
US$ ३०.५८
High
US$ ३०.७४
Low
US$ २८.७९
Mkt. cap
२.१५ अरब
Avg. vol.
२३.३३ लाख
Volume
०.००
52-wk high
US$ ५६.०४
52-wk low
US$ २३.०५
EPS
-US$ ५.८६
Beta
१.०६
Shares outstanding
७.२१ करोड
No. of employees
३६१
Open
US$ ३०.५८
High
US$ ३०.७४
Low
US$ २८.७९
Mkt. cap
२.१५ अरब
Avg. vol.
२३.३३ लाख
Volume
०.००
52-wk high
US$ ५६.०४
52-wk low
US$ २३.०५
EPS
-US$ ५.८६
Beta
१.०६
Shares outstanding
७.२१ करोड
No. of employees
३६१
News stories
From web sources and news partners
About Vera Therapeutics, Inc
CEO-
Employees३६१
Founded२०१६
HeadquartersBrisbane, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websiteveratx.com
Analyst ratings
Based on 12 analysts giving stock ratings to VERA in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for VERA in the last 3 months.
Highest
Current US$ २९.८३
US$ १००.०० (+२३५.२३%)
Average
US$ ७५.४० (+१५२.७७%)
Lowest
US$ ३४.०० (+१३.९८%)
Analyst
Recommendation
Action
Price target
Projected
Date
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
US$ ९०.००
+२०१.७%
10/01/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ ५९.००
+९७.८%
09/16/2026
Laura Chico
Wedbush
Hold
Maintained
US$ ३४.००
+१४%
09/16/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
-
-
09/15/2026
Dina Ramadane
Bank of America Securities
Buy
Reiterated
US$ ६६.००
+१२१.३%
09/15/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
US$ ७०.००
+१३४.७%
09/15/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
US$ ९०.००
+२०१.७%
09/15/2026
Ryan Deschner
Raymond James
Buy
Maintained
-
-
09/15/2026
Ritu Baral
TD Cowen
Buy
Maintained
US$ ७८.००
+१६१.५%
08/31/2026
Vamil Divan
Guggenheim
Buy
Reiterated
US$ ७६.००
+१५४.८%
08/14/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Maintained
US$ १००.००
+२३५.२%
08/10/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
US$ ९१.००
+२०५.१%
07/09/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
US$ ७०.००
+१३४.७%
06/11/2026
Paul Choi
Goldman Sachs
Buy
Maintained
US$ ९०.००
+२०१.७%
06/05/2026
Andy Chen
Wolfe Research
Buy
Maintained
US$ ८८.००
+१९५%
06/02/2026
Unknown Analyst
Wedbush
Hold
Maintained
US$ ३५.००
+१७.३%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
५.६५ करोड
५.९३ करोड
८.६० करोड
६.०१ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.७५ करोड
३.४९ करोड
३.९१ करोड
५.२४ करोड
Operating expense
८.३९ करोड
९.४२ करोड
१२.५१ करोड
११.२५ करोड
Total operating expenses
८.३९ करोड
९.४२ करोड
१२.५१ करोड
११.२५ करोड
Operating income
-८.३९ करोड
-९.४२ करोड
-१२.५१ करोड
-११.२५ करोड
Other non operating income
-१.३७ लाख
-३.०३ लाख
-३२.०० हजार
-४.८३ लाख
EBT including unusual items
-८.०३ करोड
-९.११ करोड
-१२.१० करोड
-१०.९५ करोड
EBT excluding unusual items
-८.०३ करोड
-९.०९ करोड
-१२.०६ करोड
-१०.९५ करोड
Income tax expense
-
१.०० हजार
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-८.०३ करोड
-९.११ करोड
-१२.१० करोड
-१०.९५ करोड
Net profit margin
-
-
-
-
Earnings per share
-१.२६
-१.३९
-१.६९
-१.५२
Interest and investment income
५७.३६ लाख
५५.१७ लाख
६३.५५ लाख
५३.४८ लाख
Interest expense
-१९.६० लाख
-१९.०४ लाख
-१८.२३ लाख
-१८.४८ लाख
Net interest expenses
३७.७६ लाख
३६.१३ लाख
४५.३२ लाख
३५.०० लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-८.३८ करोड
-९.४१ करोड
-१२.५० करोड
-११.२४ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू